This health insurance provider plans to cut in-clinic asthma treatments from Texas plans
Asthma doctors say the move will put their patients at risk of life-threatening reactions when they take the drugs at home.
Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Rani Therapeutics will host a conference call and live webcast at 4:30 p.m. ET / 1:30 p.m. PT on March 31, 2025. Individuals interested in listening to the live conference call may do so by using the ...
Irish Mirror on MSN22h
The Script drummer Glen Power breaks social media silence as he reveals health challenge
The Script 's drummer Glen Power has broken his social media silence, revealing he had to get stem cell treatment on his ...
Medical Dialogues21h
FDA Expands Approval of wearable furosomide delvery system for CKD-Related Edema
The US Food and Drug Administration (FDA) has broadened the approval of Furoscix® (furosemide injection) to treat edema in ...
CHEK News20h
‘A sense of relief’: Charleigh’s bi-weekly medication funded for another three months: mom
Funding for Charleigh's life-sustaining medication has been extended for another three months, according to her mom.
Everyday Health22h
What Is IV Nutrition Therapy — and Does It Work?
IV nutrition therapy is commonly used in medical settings but is gaining popularity in wellness circles. Learn the potential ...
Alphamab Oncology Reports Full Year 2024 Financial Results and Business Highlights
Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress.